NCT01316094View on ClinicalTrials.gov

A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

PHASE3CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

January 18, 2011

Primary Completion Date

November 28, 2012

Study Completion Date

November 28, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ASP1941

oral

DRUG

placebo

oral

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY